Soleus Capital Management, L.P. Werewolf Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$3.71 - $12.22 $239,610 - $789,228
-64,585 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$11.48 - $17.65 $5.73 Million - $8.8 Million
-498,811 Reduced 88.54%
64,585 $769,000
Q2 2021

Aug 16, 2021
BUY
$11.6 - $17.44 $6.54 Million - $9.83 Million
563,396 New
563,396 $9.83 Million

Others Institutions Holding HOWL

# of Institutions
69
Shares Held
31.8M
Call Options Held
700
Put Options Held
500
View Full List

About Werewolf Therapeutics, Inc.

HOWL Quotes by TradingView
  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $47M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email